Stimulating the development of drug treatments to improve cognition in schizophrenia

Keyphrases

• Drug Treatment 100%
• Schizophrenia 100%
• Illness 16%
• Clinical Symptoms 16%
• Negative Symptoms 16%
• Cognitive Impairment 16%
• Public Health Risk 16%
• Clinical Trials 16%
• U.S. Food 16%
• Drug Development 16%
• New Drugs 16%
• Development Policy 16%
• Clinical Targets 16%
• Functional Benefit 16%
• Neuropharmacological 16%
• Community Function 16%
• Poor Communities 16%
• National Institute of Mental Health 16%
• Drug Approval 16%
• Daily Functioning 16%
• Clinical Trials Network 16%
• Academic Interest 16%
• MATRICS 16%
• Clinical Drugs 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Pharmacotherapy 100%
• Drug Development 50%
• Drug Approval 50%
• Negative Syndrome 50%
• Symptom 50%
• Cognitive Defect 50%
• Disease 50%